- -

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial

Mostrar el registro sencillo del ítem

Ficheros en el ítem

dc.contributor.author Rossetti, Paolo es_ES
dc.contributor.author Ampudia Blasco, F. Javier es_ES
dc.contributor.author Laguna Sanz, Alejandro José es_ES
dc.contributor.author Revert Tomás, Ana es_ES
dc.contributor.author Vehí Casellas, Josep es_ES
dc.contributor.author Ascaso, Juan F. es_ES
dc.contributor.author Bondía Company, Jorge es_ES
dc.date.accessioned 2013-07-15T13:02:56Z
dc.date.available 2013-07-15T13:02:56Z
dc.date.issued 2012
dc.identifier.issn 1520-9156
dc.identifier.uri http://hdl.handle.net/10251/31150
dc.description This is a copy of an article published in the Diabetes Technology and Therapeutics © 2012 [copyright Mary Ann Liebert, Inc.]; Diabetes Technology and Therapeutics is available online at: http://online.liebertpub.com. es_ES
dc.description.abstract [EN] Objective: Prandial insulin dosing is an empirical practice associated frequently with poor reproducibility in postprandial glucose response. Based on continuous glucose monitoring (CGM), a method for prandial insulin administration (iBolus) is presented and evaluated for people with type 1 diabetes using CSII therapy. Subjects and Methods: An individual patient¿s model for a 5-h postprandial period was obtained from 6-day ambulatory CGM and used for iBolus calculation in 12 patients with type 1 diabetes. In a double-blind, crossover study each patient underwent four meal tests with 40 g or 100 g of carbohydrates (CHOs), both on two occasions. For each meal, the iBolus or the traditional bolus (tBolus) was given before mealtime (t 0) in a randomized order. We measured the postprandial glycemic response as the area under the curve of plasma glucose (AUC-PG0¿5h) and variability as the individual coef¿cient of variation (CV) of AUC-PG0¿5h. The contribution of the insulin-to-CHO ratio, CHO, plasma glucose at t 0 (PGt0), and insulin dose to AUC-PG0¿5h and its CV was also investigated. Results: AUC-PG0¿5h was similar with either bolus for 40-g (iBolus vs. tBolus, 585.5¿127.5 vs. 689.2¿180.7 mg/dL$h) or 100-g (752.1¿237.7 vs. 760.0¿263.2 mg/dL$h) CHO meals. A multiple regression analysis revealed a signi¿cant model only for the tBolus, with PGt0 being the best predictor of AUC-PG0¿5h explaining approximately 50% of the glycemic response. Observed variability was greater with the iBolus (CV, 16.7¿15.3% vs. 10.1¿12.5%) but independent of the factors studied. Conclusions: A CGM-based algorithm for calculation of prandial insulin is feasible, although it does not reduce unpredictability of individual glycemic responses. Causes of variability need to be identi¿ed and analyzed for further optimization of postprandial glycemic control. es_ES
dc.description.sponsorship We are grateful to Mrs. Sara Correa, Fundacion INCLIVA-Hospital Clinico Universitario de Valencia, and Mrs. Geles Viguer, Hospital Clinico Universitario de Valencia, for their invaluable help in conducting the study. We also thanks Dr. Carmine Fanelli, University of Perugia, Dr. Howard Zisser, Sansum Diabetes Research Institute, and Prof. Alberto Ferrer, Universitat Politecnica de Valencia, for their suggestions on study design and data analysis. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007/2013) under grant agreement 252085 and from the Spanish Ministry of Science under grants DPI2010-20764-C02-01 and DPI2011-28112-C04-01. en_EN
dc.language Inglés es_ES
dc.publisher Mary Ann Liebert es_ES
dc.relation.ispartof Diabetes Technology & Therapeutics es_ES
dc.rights Reserva de todos los derechos es_ES
dc.subject.classification INGENIERIA DE SISTEMAS Y AUTOMATICA es_ES
dc.title Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.1089/dia.2012.0145
dc.relation.projectID info:eu-repo/grantAgreement/MICINN//DPI2010-20764-C02-01/ES/NUEVAS ESTRATEGIAS DE CONTROL GLUCEMICO POSTPRANDIAL MEDIANTE TERAPIA CON BOMBA DE INSULINA EN DIABETES TIPO 1/ es_ES
dc.relation.projectID info:eu-repo/grantAgreement/EC/FP7/252085/EU/Seeking solutions for the artificial pancreas: new methods for improving continuous glucose monitoring and closed-loop postprandial glycaemic control./ en_EN
dc.relation.projectID info:eu-repo/grantAgreement/MICINN//DPI2011-28112-C04-01/ES/MONITORIZACION, INFERENCIA, OPTIMIZACION Y CONTROL MULTI-ESCALA: DE CELULAS A BIORREACTORES/ es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Ingeniería de Sistemas y Automática - Departament d'Enginyeria de Sistemes i Automàtica es_ES
dc.contributor.affiliation Universitat Politècnica de València. Instituto Universitario de Automática e Informática Industrial - Institut Universitari d'Automàtica i Informàtica Industrial es_ES
dc.description.bibliographicCitation Rossetti, P.; Ampudia Blasco, FJ.; Laguna Sanz, AJ.; Revert Tomás, A.; Vehí Casellas, J.; Ascaso, JF.; Bondía Company, J. (2012). Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing - the iBolus - in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial. Diabetes Technology & Therapeutics. 14(11):1043-1052. https://doi.org/10.1089/dia.2012.0145 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion http://dx.doi.org/10.1089/dia.2012.0145 es_ES
dc.description.upvformatpinicio 1043 es_ES
dc.description.upvformatpfin 1052 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 14 es_ES
dc.description.issue 11 es_ES
dc.relation.senia 240830
dc.identifier.eissn 1557-8593
dc.identifier.pmid 23003329 en_EN
dc.identifier.pmcid PMC3482847 en_EN
dc.contributor.funder European Commission
dc.contributor.funder Ministerio de Ciencia e Innovación


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem